EWL:FRA
Edwards Lifesciences Corp
€74.70
arrow_downward
-0.29%(-0.22) 1D
Oct 9, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EWL...
Open
€74.74
High
€75.98
Low
€74.38
Mkt. cap
49.12B
Avg. vol.
39.00
Volume
0.00
52-wk high
€83.52
52-wk low
€59.49
No. of employees
16K
Open
€74.74
High
€75.98
Low
€74.38
Mkt. cap
49.12B
Avg. vol.
39.00
Volume
0.00
52-wk high
€83.52
52-wk low
€59.49
No. of employees
16K
News stories
From web sources and news partners
Investing.com Nigeria
·
1 day ago
Edwards Lifesciences CVP Daniel Lippis sells $53k in stock By Investing.com
Investing.com Nigeria
·
1 day ago
Form 4 Edwards Lifesciences Corp For: 9 October By Investing.com
MarketBeat
·
1 day ago
Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares of Stock
Investing.com
·
2 days ago
UBS reiterates Edwards Lifesciences stock rating on endpoint expectations
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com